High Tiam1 expression was also associated with higher relapse rates, higher mortality, lymph node metastasis, and stage III/IV cancers as compared with low Tiam1 expression (all P < 0.05). Here, TIAM1 is linked to metastatic malignant neoplasm in the lymph nodes.